Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: A summary of evidence

Journal of Neural Transmission

Volumn 116, Issue 3, 2009, Pages 319-331

  Lukban, Marissa Barlaan ^a   Rosales, Raymond L ^b   Dressler, Dirk ^c  

^a UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^b UNIVERSITY OF SANTO TOMAS HOSPITAL   (Philippines)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Botulinum toxin; Cerebral palsy; Review; Spasticity

Indexed keywords

BOTULINUM TOXIN A;

ARM; CAST APPLICATION; CEREBRAL PALSY; DRUG EFFICACY; DRUG SAFETY; DYSPHAGIA; ELECTROSTIMULATION; FALLING; FECES INCONTINENCE; FEVER; FLU LIKE SYNDROME; HUMAN; INCONTINENCE; INJECTION SITE PAIN; LEG; LIMB WEAKNESS; MICTURITION; NAUSEA; OCCUPATIONAL THERAPY; PES EQUINOVARUS; PHYSIOTHERAPY; PRIORITY JOURNAL; REVIEW; SEIZURE; SIDE EFFECT; SPASTICITY; TREATMENT OUTCOME; VOMITING; WEAKNESS;

BOTULINUM TOXINS, TYPE A; CEREBRAL PALSY; CHILD; CLINICAL TRIALS AS TOPIC; HUMANS; INJECTIONS, INTRAMUSCULAR; LOWER EXTREMITY; MUSCLE SPASTICITY; MUSCLE TONUS; MUSCLE WEAKNESS; NEUROMUSCULAR AGENTS; PAIN; TREATMENT OUTCOME; UPPER EXTREMITY;

EID: 61849133915     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-008-0175-8     Document Type: Review

References (62)

1. JD Ackman BS Russman SS Thomas 2005 Comparing botulinum toxin A with casting for treatment of dynamic equinus in children with cerebral palsy Dev Med Child Neurol 47 620 627
2. Ade-Hall RA, Moore AP (2000) Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy. The Cochrane Database of Systematic Reviews. The Cochrane Library
3. B Ashworth 1964 Preliminary trial of carisoprodol in multiple sclerosis Practitioner 192 540 542
4. R Baker M Jasinski I Maciag-Tymecka J Michalowska-Mrozek M Bonikowski L Carr 2002 Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double-blind, placebo-controlled, dose ranging study Dev Med Child Neurol 44 666 675
5. K Bjornson R Hays C Graubert 2007 Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation Pediatrics 120 49 58
6. RW Bohannon MB Smith 1987 Interrater reliability of a modified Ashworth scale of muscle spasticity Phys Ther 67 206 207
7. M Bottos MG Benedetti P Salucci 2003 Botulinum toxin with and without casting in ambulant children with spastic diplegia: a clinical and functional assessment Dev Med Child Neurol 45 758 762
8. RN Boyd RM Hays 2001 Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review Eur J Neurol 8 Suppl 5 1 20
9. RN Boyd V Pliatsios R Starr R Wolfe HK Graham 2000 Biomechanical transformation of the gastroc-soleus muscle with botulinum toxin A in children with cerebral palsy Dev Med Child Neurol 42 32 41
10. RN Boyd F Dobson J Parrott S Love J Oates A Larson 2001 The effect of botulinum toxin type A and a variable hip abduction orthosis on gross motor function: a randomized controlled trial Eur J Neurol 8 Suppl 5 109 119
11. ES Cardoso MD Rodriguez M Barroso 2006 Botulinum toxin type A for the treatment of spastic equines foot in cerebral palsy Pediatr Neurol 34 106 109
12. IS Corry AP Cosgrove EG Walsh D McClean HK Graham 1997 Botulinum toxin A in the hemiplegic upper limb: a double blind trial Dev Med Child Neurol 39 185 193
13. IS Corry AP Cosgrove CM Duffy 1998 Botulinum toxin A compared with stretching casts in the treatment of spastic equines: a randomized prospective trial J Pedia Orthop 18 304 311
14. DeMatteo C, Law M, Russell D, Pollock N, Rosenbaum P, Walter S (1992) QUEST: quality of upper extremity skills test. McMaster University, Neurodevelopmental Clinical Research Unit, Hamilton
15. K Desloovere G Molenaers I Jonkers J De Cat L De Borre J Nijs M Eyssen P Pauwels P De Cock 2001 A randomized study of combined botulinum toxin type A and casting in the ambulant child with cerebral palsy using objective outcome measures Eur J Neurol 8 Suppl 5 75 87
16. C Detrembleur TM Lejeune A Renders 2002 Botulinum toxin and short term electrical stimulation in the treatment of equinus in cerebral palsy Mov Disord 17 162 169
17. Edlund W, Gronceth G, SoY, Franklin G (2004) American Academy of Neurology Clinical Practice Guideline Process Manual
18. D Fehlings M Rang J Glazier C Steele 2000 An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy J Pediatr 137 331 337
19. Fisher AG (2003) AMPS: assessment of motor and process skills volume 1: development, standardization, and administration manual, 5th edn. Three Star Press Inc, Fort Collins
20. PJ Flett LM Stern H Waddy 1999 Botulinum toxin A versus fixed cast stretching for dynamic calf tightness in cerebral palsy J Paediat Child Health 35 71 77
21. K Garces A McCormick L McGahan B Skidmore 2005 Botulinum toxin A for upper and lower limb spasticity: a systematic review Can Coordin Off Health Technol Assess 51 1 70
22. M Goldstein 2004 The treatment of cerebral palsy: what we know, what we don't know J Pediatr 145 S42 S45
23. G Hagglund S Andersson H Duppe HL Pedertsen E Nordmark L Westbo 2005 Prevention of severe contractures might replace multilevel surgery in cerebral palsy: results of a population-based health care programme and new techniques to reduce spasticity J Pediatr Orthop 14 269 273
24. Haley SM, Coster SJ, Ludlow LH, Haltiwanger JT, Andrellos PJ (1992) Pediatric evaluation of disability inventory (PEDI): development, standardization, and administration manual. New England Medical Center and PEDI Research Group, Boston
25. F Heinen G Molenaers C Fairhurst LJ Carr K Desloovere EC Valayer E Morel AS Papavassiliou K Tedroff SI Pascual-Pascual G Bernert S Berweck G Di Rosa E Kolanowski I Krageloh-Mann 2006 European consensus table 2006 on botulinum toxin for children with cerebral palsy Eur J Paediatr Neurol 15 215 225
26. LM Johnson MJ Randall DS Reddihough LE Oke TA Byrt TM Bach 1994 Development of a clinical assessment of quality of movement for unilateral upper-limb function Dev Med Child Neurol 36 965 973
27. Kiresuk TJ, Smith A, Cardillo JE (1994) Goal attainment scaling: applications, theory, and measurement. Lawrence Erlbaum Associates, Hillsdale
28. LA Koman JP Mooney BP Smith 1993 Management of spasticity in cerebral palsy with botulinum toxin A: preliminary investigation J Pediatr Orthop 13 489 495
29. LA Koman JF Mooney BP Smith 1994 Management of spasticity in cerebral palsy with Botulinum A toxin: report of a preliminary, randomized, double blind trial J Pediatr Orthop 14 299 303
30. LA Koman JF Mooney BP Smith F Walker JM Leon BOTOX Study Group 2000 Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial J Pediatr Orthop 20 108 115
31. N Lannin A Scheinberg K Clark 2006 AACPDM systematic review of the effectiveness of therapy for children with cerebral palsy after botulinum toxin A injections Dev Med Child Neurol 48 533 539
32. Law M, Baptiste S, Carswell A, McColl MA, Polatajko H, Pollock N (1998) Canadian occupational performance measure, 2nd edn. Canadian Association of Occupational Therapists, Toronto
33. SC Love JP Valentine EM Blair CJ Price JH Cole PJ Chauvel 2001 The effect of botulinum toxin type A on the functional ability of the child with spastic hemiplegia a randomized controlled trial Eur J Neurol 8 Suppl 5 50 58
34. K Lowe I Novak A Cusick 2006 Low dose/high concentration localized botulinum toxin A improves upper limb movement and function in children with hemiplegic cerebral palsy Dev Med Child Neurol 48 170 175
35. MB Lukban MS Fojas EL Avendano FA delos Reyes SD Ignacio RL Rosales 2006 The management of spasticity in children with cerebral palsy: Consensus Statement of the Philippine Society of Neurorehabilitation Neurorehabil Neural Repair 20 198 199 (abstract)
36. KG Maathuis CP van der Schans A van Iperen HS Rietman JH Geertzen 2005 Gait in children with cerebral palsy: observer reliability of Physician Rating Scale and Edinburgh Visual Gait Analysis Interval Testing scale J Pediatr Orthop 25 268 272
37. V Mall F Heinen A Siebel 2006 Treatment of adductor spasticity with BTX-A in children with CP: a randomized, double-blind, placebo-controlled study Dev Med Child Neurol 48 10 13
38. V Mathrowitz K Weber N Kashman G Volland 1985 Adult norms for the nine hole peg test of finger dexterity Occup Ther J Res 5 24 38
39. JN Panicker UB Muthane 2003 Botulinum toxins: pharmacology and its current therapeutic evidence for use Neurology India 51 455 460
40. ES Park D Rha 2006 Botulinum toxin type A injection for management of upper limb spasticity in children with cerebral palsy: a literature review Yonsei Med J 47 589 603
41. FS Pidcock 2004 The emerging role of the therapeutic botulinum toxin in the treatment of cerebral palsy J Pediatr 145 S33 S35
42. Randall MJ, Johnson LM, Reddihough DS (1999) The Melbourne assessment of unilateral upper limb function. Royal Children's Hospital Melbourne, Melbourne
43. A Reeuwijk PEM van Schei JG Becher G Kwakkei 2006 Effects of botulinum toxin type A on upper limb function in children with cerebral palsy: a systematic review Clin Rehabil 20 375 387
44. RL Rosales 2008 Chua-Yap A: evidence-based systematic review on the efficacy and safety of botulinum toxin therapy in post-stroke spasticity J Neural Transm 115 617 623
45. RL Rosales D Dressler H Bigalke 2006 Pharmacologic differences between botulinum toxins Eur J Neurol 13 2 10
46. P Rosenbaum D Stewart 2004 The World Health Organization International Classification of Functioning, Disability, and Health: a model to guide clinical thinking, practice and research in the field of cerebral palsy Semin Pediatric Neurol 11 5 10
47. FJ Ruiz JF Guest A Lehmann AM Davie K Guttler O Schluter G Dreiss 2004 Costs and consequences of botulinum toxin type A use management of children with cerebral palsy in Germany Eur J Health Econ 5 227 235
48. DJ Russell PL Rosenbaum DT Cadman C Gowland S Hardy S Jarvis 1989 The gross motor function measure: a means to evaluate the effects of physical therapy Dev Med Child Neurol 31 341 352
49. BS Russman A Tilton ME Gormley 1997 Cerebral palsy: a rational approach to a treatment protocol and the role of botulinum toxin in treatment Muscle Nerve 20 Suppl 6 S1 S11
50. RN Russo M Crotty MD Miller 2007 Upper-limb botulinum toxin A injection and occupational therapy in children with hemiplegic cerebral palsy identified from a population register: a single-blind, randomized, controlled trial Pediatrics 119 1149 1158
51. TD Sanger SN Kukke S Sherman-Levine 2007 Botulinum toxin improves the speed of reaching in children with cerebral palsy and arm dystonia: an open-label, dose escalation pilot study J Child Neurology 22 116 122
52. VA Scholtes AJ Dallmeijer DL Knol LA Speth CG Maathuis PH Jongerius JG Becher 2007 Effect of multilevel botulinum toxin A and comprehensive rehabilitation on gait in cerebral palsy Pediatr Neurol 36 30 39
53. A Schwerin S Berweck IM Fletzek F Helnen 2004 Botulinum toxin B treatment in children with spastic movement disorders: a pilot study Pediatr Neurol 31 109 113
54. DM Simpson JM Gracies HK Graham JM Miyasaki M Naumann B Russman LL Simpson Y So 2008 Assessment: botulinum neurotoxin for the treatment of spasticity (an evidenced based review) Neurology 70 1691 1698
55. LA Speth P Leffers YJ Janssen-Potten 2005 Botulinum toxin A and upper limb functional skills in hemiparetic cerebral palsy: a randomized trial in children receiving intensive therapy Dev Med Child Neurol 47 468 473
56. DH Sutherland KR Kaufman MP Wyatt HG Chambers SJ Mubarak 1999 Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy Gait Posture 10 1 9
57. G Tardieu S Shentoub R Delarue 1954 A la recherche d'une technique de mesure de la spasticite imprime avec le periodique Neurologique 91 143 144
58. T Ubhi BB Bhakta HL Ives V Allgar SH Roussounis 2000 Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy Arch Dis Child 83 481 487
59. JW Varni M Seid PS Kurtin 2001 PedsQL4.0: reliability and validity of the pediatric quality of life inventory version 4.0 generic core scales in healthy and patient populations Med Care 39 800 812
60. M Wallen SJ O'Flaherty MC Waugh 2007 Functional outcomes of intramuscular botulinum toxin type A and occupational therapy in the upper limbs of children with cerebral palsy: a randomized controlled trial Arch Phys Med Rehabil 88 1 10
61. Wasiak J, Hoare B, Wallen M (2004) Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy. Cochrane Database Syst Rev (4):1-25 (CD003469)
62. Waters E, Salmon L, Wake M, Wright M, Hesketh K (1999) Australian authorised adaptation of the child health questionnaire. Centre for Community Child Health, Royal Children's Hospital Melbourne, Melbourne